AU8851298A - L-threonate ferrous, as well as pharmaceutical composition and use for improvingand treating human anemia thereof - Google Patents

L-threonate ferrous, as well as pharmaceutical composition and use for improvingand treating human anemia thereof

Info

Publication number
AU8851298A
AU8851298A AU88512/98A AU8851298A AU8851298A AU 8851298 A AU8851298 A AU 8851298A AU 88512/98 A AU88512/98 A AU 88512/98A AU 8851298 A AU8851298 A AU 8851298A AU 8851298 A AU8851298 A AU 8851298A
Authority
AU
Australia
Prior art keywords
improvingand
threonate
ferrous
well
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU88512/98A
Other languages
English (en)
Inventor
Fuping Kou
Zhiwen Wang
Kai Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEIJING JUNENG ASIA-PACIFIC LIFE SCIENTIFIC RESEARCH CENTER
Original Assignee
Beijing Juneng Asia Pacific Life Scient Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Juneng Asia Pacific Life Scient Research Center filed Critical Beijing Juneng Asia Pacific Life Scient Research Center
Publication of AU8851298A publication Critical patent/AU8851298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU88512/98A 1997-08-29 1998-08-28 L-threonate ferrous, as well as pharmaceutical composition and use for improvingand treating human anemia thereof Abandoned AU8851298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN97116835 1997-08-29
CN97116835A CN1053653C (zh) 1997-08-29 1997-08-29 新l－苏糖酸衍生物
PCT/CN1998/000174 WO1999011256A1 (en) 1997-08-29 1998-08-28 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof

Publications (1)

Publication Number Publication Date
AU8851298A true AU8851298A (en) 1999-03-22

Family

ID=5174140

Family Applications (1)

Application Number Title Priority Date Filing Date
AU88512/98A Abandoned AU8851298A (en) 1997-08-29 1998-08-28 L-threonate ferrous, as well as pharmaceutical composition and use for improvingand treating human anemia thereof

Country Status (9)

Country Link
US (1) US6313170B1 (enExample)
EP (1) EP1038524B1 (enExample)
JP (1) JP2001514219A (enExample)
KR (1) KR100615537B1 (enExample)
CN (1) CN1053653C (enExample)
AU (1) AU8851298A (enExample)
DE (1) DE69832722T2 (enExample)
HK (1) HK1032534A1 (enExample)
WO (1) WO1999011256A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074762C (zh) * 1998-08-18 2001-11-14 北京巨能亚太生命科学研究中心 L－苏糖酸铬盐、其制备方法及其应用
CN1196480C (zh) * 2001-07-03 2005-04-13 北京巨能亚太生命科学研究中心 L－苏糖酸钙在制备预防或治疗骨折的药物中的用途
JP4300753B2 (ja) * 2001-05-31 2009-07-22 味の素株式会社 貧血抑制剤及び食欲抑制剤
CN1197561C (zh) * 2001-07-03 2005-04-20 北京巨能亚太生命科学研究中心 L－苏糖酸钙在制备预防或治疗损及软骨的疾病的药物中的用途
AU2008227465B2 (en) * 2007-03-22 2014-02-06 Magceutics, Inc. Magnesium compositions and uses thereof
US8142803B2 (en) 2007-03-22 2012-03-27 Magceutics, Inc. Magnesium compositions and uses thereof for neurological disorders
WO2011003045A1 (en) * 2009-07-01 2011-01-06 Magceutics, Inc. Slow release magnesium composition and uses thereof
CN104961636B (zh) * 2015-07-14 2016-08-31 启东东岳药业有限公司 L-苏糖酸镁合成方法
CN108289875A (zh) 2015-09-11 2018-07-17 纽罗森特里亚股份有限公司 苏糖酸盐化合物及其使用方法
CN105326855A (zh) * 2015-10-27 2016-02-17 南京大学 易吸收复合夹层式螯合镁钙片
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4611067A (en) * 1985-01-31 1986-09-09 Merck & Co., Inc. Process for the preparation of HMG-CoA reductase inhibitors and intermediate compounds employed therein
US4582914A (en) * 1985-01-31 1986-04-15 Merck & Co., Inc. Process for the preparation of HMG-CoA reductase inhibitors
US5070085A (en) * 1987-04-10 1991-12-03 Oxycal Laboratories, Inc. Compositions and methods for administering therapeutically active compounds
WO1990012571A1 (en) * 1989-04-07 1990-11-01 Oxycal Laboratories, Inc. Compositions and methods for administering vitamin c
JPH0678247B2 (ja) * 1988-10-04 1994-10-05 大塚製薬株式会社 Ｎｍｒ造影用鉄含有製剤
JPH03291231A (ja) 1990-04-06 1991-12-20 Asahi Breweries Ltd 貧血改善剤
CN1060216A (zh) * 1990-09-25 1992-04-15 奥克斯可尔公司 含有治疗活性化合物的组合物及其施用方法
CN1228409A (zh) * 1998-03-05 1999-09-15 江西赣江制药有限责任公司 L－苏糖酸和苏糖酸盐(或酯)的制剂

Also Published As

Publication number Publication date
KR20010023461A (ko) 2001-03-26
CN1053653C (zh) 2000-06-21
WO1999011256A1 (en) 1999-03-11
US6313170B1 (en) 2001-11-06
EP1038524B1 (en) 2005-12-07
EP1038524A1 (en) 2000-09-27
KR100615537B1 (ko) 2006-08-25
WO1999011256A8 (en) 1999-08-05
HK1032534A1 (en) 2001-07-27
DE69832722D1 (de) 2006-01-12
DE69832722T2 (de) 2006-09-07
EP1038524A4 (en) 2002-08-07
JP2001514219A (ja) 2001-09-11
CN1200366A (zh) 1998-12-02

Similar Documents

Publication Publication Date Title
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
AU4254696A (en) Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
HUP9801175A3 (en) Topically applied pharmaceutical composition, method of preparing it and its use
NZ302926A (en) Composition for use as antihistamines comprising piperidinoalkanol derivatives and inert ingredients
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
PH30768A (en) Cosmetic composition for treatment of pimples and redness.
DE69826683D1 (de) Therapeutische zusammensetzungen, enthaltend amlopidin und atorvastatin
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
AU6062498A (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
NZ513650A (en) Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo
HUP9802132A3 (en) Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
HUP0001940A3 (en) Benzisothiazole derivatives, their use and pharmaceutical compositions containing them
AU2068295A (en) Skin treatment composition
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
AU7961498A (en) 9a-azalides, compositions containing such compounds and methods of treatment
HUP9802590A3 (en) Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them
PL311915A1 (en) Pharmaceutic, dermatological and cosmetic composition
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
ZA961983B (en) Bicyclic compounds, preparation thereof and use in pharmaceutical compositions.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase